Levine A¹, Rhodes JM², Lindsay JO³, Abreu MT⁴, Kamm MA⁵, Gibson PR⁶, Gasche C⁷, Silverberg MS⁸, Mahadevan U⁹, Sigall Boneh R¹, Wine E¹⁰, Damas OM⁴, Syme G¹¹, Trakman GL⁵, Yao CK⁶, Stockhamer SI⁸, Hammami MB⁹, Garces LC⁴, Rogler G¹², Koutroubakis IE¹³, Ananthakrishnan A¹⁴, Liam M¹⁵, Lewis JD¹⁵. Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30185-3. doi: 10.1016/j.cgh.2020.01.046. [Epub ahead of print]

Author information

1 Pediatric IBD Center, Wolfson Medical Center Holon, Tel Aviv University, Israel.

2 Institute of Translational Medicine, University of Liverpool, UK.

3 Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London,UK.

4 Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, USA.

5 St Vincent's Hospital and University of Melbourne, Australia.

6 Monash University and Alfred Health, Melbourne, Austarlia.

7 Medical University Vienna, Austria.

8 Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, University of Toronto, Toronto, Canada.

9 University of California, San Francisco, USA.

10 Departments of Pediatrics & Physiology, University of Alberta, Canada.

11 The Royal London Hospital, Barts Health NHS Trust, London, UK.

12 University Hospital, Zurich, Switzerland.

13 University Hospital of Heraklion, Heraklion Greece.

14 Massachusetts General Hospital, Boston, USA.

15 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA.

Abstract

Recent evidence points to a plausible role of diet and the microbiome in the pathogenesis of both Crohn's disease(CD) and Ulcerative Colitis (UC). Dietary therapies based on exclusion of table foods and replacement with nutritional formulas and/or a combination of nutritional formulas and specific table foods may induce remission in CD. In UC, specific dietary components have also been associated with flare of disease. While evidence of varying quality has identified potential harmful or beneficial dietary components, physicians and patients at the present time do not have guidance as to which foods are safe, may be protective or deleterious for these diseases. The current document has been compiled by the nutrition cluster of the International Organization of IBD (IOIBD) based on the best current evidence to provide expert opinion regarding specific dietary components, food groups and food additives that may be prudent to increase or decrease in the diet of patients with IBD to control and prevent relapse of IBD.